Instadose Pharma (Instadose Pharma) Total Stockholders Equity : $28.05 Mil (As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Total Stockholders Equity?

Instadose Pharma's Total Stockholders Equity for the quarter that ended in Feb. 2022 was $28.05 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Instadose Pharma's Book Value per Share for the quarter that ended in Feb. 2022 was $0.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Instadose Pharma's Debt-to-Equity for the quarter that ended in Feb. 2022 was 0.01.

Instadose Pharma Total Stockholders Equity Historical Data

The historical data trend for Instadose Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Total Stockholders Equity Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Total Stockholders Equity

Get a 7-Day Free Trial

-0.01

-0.03

-0.06

-0.08

-0.17

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
Total Stockholders Equity	Get a 7-Day Free Trial															-0.01	-0.06	-0.11	-0.17	28.05

Instadose Pharma (OTCPK:INSD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Instadose Pharma's Book Value per Share for the quarter that ended in Feb. 2022 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(28.053	-	0)	/	531.934
	=	0.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Instadose Pharma's Debt-to-Equity for the quarter that ended in Feb. 2022 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.123	+	0.065)	/	28.053
	=	0.01

Instadose Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.